Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomised trials-Reference-Cited by-同舟云学术

Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomised trials

Published:2023-04 Issue:10384 Volume:401 Page:1293-1301
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Ridker Paul M,Bhatt Deepak L,Pradhan Aruna D,Glynn Robert J,MacFadyen Jean G,Nissen Steven E

Publisher

Elsevier BV

Subject

General Medicine

Reference30 articles.

1. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men;Ridker;N Engl J Med,1997

2. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women;Ridker;N Engl J Med,2000

3. New and emerging therapies for reduction of LDL-cholesterol and apolipoprotein B;Nurmohamed;J Am Coll Cardiol,2021

4. The dawn of a new era of targeted lipid-lowering therapies;Tokgözoğlu;Eur Heart J,2022

5. Evaluating the association between low-density lipoprotein cholesterol reduction and relative and absolute effects of statin treatment: a systemic review and meta-analysis;Byrne;JAMA Intern Med,2022

Cited by 198 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comprehensive retrospect on biomarkers indicating vascular failure;Vascular Failure;2024-12-01

2. Reagent-free anti-fouling electrochemical immunosensor based on AL-BSA/AuNPs/PANI coating for the point-of-care detection of C-reactive protein in plasma and whole blood;Biosensors and Bioelectronics;2024-11

3. Effect of colchicine on progression of known coronary atherosclerosis in patients with STable CoROnary artery disease CoMpared to placebo (EKSTROM) trial—rationale and design;American Heart Journal;2024-11

4. Inflammatory biomarkers and long-term outcome in young patients three months after a first myocardial infarction;Cytokine;2024-10

5. Prognostic significance of baseline low-density lipoprotein cholesterol in patients undergoing coronary revascularization; a report from the CREDO-Kyoto registry;Journal of Cardiology;2024-10